Skip to content
  1. Start -> 1960

    January 1, 1970

    Professor MB Golant discover the effect of millimeter waves have on biological objects.

  2. 1960-2000

    January 1, 1970

    Many studies are conducted to prove what the effects of millimeter waves have on living cells.

  3. 2005

    January 1, 1970

    The whole operation is moved to Sweden.

  4. 2008-2014

    January 1, 1970

    Several studies with mice show reconstruction of the neurodegenerative systems of Parkinson’s disease mice.

  5. 2009

    January 1, 1970

    Filing of patent application for treatment of neurodegenerative diseases.

  6. 2011

    January 1, 1970

    First patent approved, patent protection in 11 countries.

  7. 2014

    January 1, 1970

    Research starts to go from a suspension to dry form, capsules.

  8. 2016

    January 1, 1970

    Studies that all show a faster recovery and increased number of immune markers in the blood.

  9. 2017

    January 1, 1970

    Research agreement signed with Sapienza University in Rome, Europe's largest university.

  10. 2018

    January 1, 1970

    Funding of ongoing operations, new partners come in and Milmed Unico AB buys all intellectual property rights from the"old Milmed AB”.

  11. 2018

    January 1, 1970

    Allergy study showed very clear indications of a positive effect against allergic disorders.

  12. 2019

    January 1, 1970

    Sapienza conducts studies showing that Milmedhas zero toxicity.

  13. 2019

    January 1, 1970

    Submission of patent application for the treatment of allergic disorders.

  14. 2020

    January 1, 1970

    Approval of patent for treatment of allergic disorders.

  15. 2021

    January 1, 1970

    New partners with Pharma competence join us.

  16. 2021

    January 1, 1970

    Collaboration agreement signed with MedicorentInt. AB.

  17. 2021 <- Today

    January 1, 1970

    We move from a suspension to dry capsules.